Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Ref: 48/SE/LC/2026-27 Date: November 4, 2026 Scrip Code BSE: 544122 NSE: ENTERO ISIN: INE010601016 Head, Listing Compliance Department Head, Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, Plot No. C/1 G Block, Mumbai - 400001 Bandra -Kurla Complex, Bandra (East), Mumbai- 400051 Dear Sir/Madam, Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Pursuant to Regulation 30(9) and Regulation 30(12) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the requisite disclosure as detailed in Annexure-A. Kindly take the above information on record. Thanking you, Yours faithfully, For Entero Healthcare Solutions Limited Sanu Kapoor Vice President – Group General Counsel, Company Secretary & Compliance Officer Annexure-A Particulars Details Name of Listed Company Entero Healthcare Solutions Limited (“Company”) Name of Subsidiary Company Vasavi Medicare Solutions Private Limited (“Vasavi”), a wholly owned subsidiary of the Company Nature of event Default in payment of outstanding dues of Vasavi by its customer M/s. S M Pharma a partnership firm Amount involved INR 11.87 crore Brief description of event The Customer has defaulted in payment of invoices raised by Vasavi aggregating to INR 11.87 crore. Vasavi has subsequently received information indicating a risk to the recoverability of these dues. Financial impact Vasavi has made a provision for the entire outstanding amount in its books of account. The maximum impact on the consolidated financial statements of the Company is INR 11.87 crore. Steps taken / next steps Vasavi is initiating appropriate legal proceedings against the Customer for recovery of the outstanding dues.